Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

312.50 -16.45 (-5.00%)
Official Closing Price Updated: 4:15 PM EDT, Aug 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,618,381
Open 320.99
Bid (Size) 311.50 (20)
Ask (Size) 313.39 (1)
Prev. Close 328.95
Today's Range 306.59 - 323.00
52wk Range 248.38 - 346.85
Shares Outstanding N/A
Dividend Yield 2.73%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's Why Eli Lilly Stock Dropped 12% Last Month
News from a competitor gave investors an unwelcome dose of reality. 
Via The Motley Fool
Amgen's Mixed Q2 Results Highlight Obesity Drug Potential, Analysts Focus Shifts To Upcoming Clinical Readouts
Amgen posted mixed Q2 results. Analysts highlight upcoming clinical readouts in obesity and inflammatory disease as crucial. Despite some underperformance, growth prospects remain strong, with... 
Via Benzinga

Performance

YTD
+5.08%
+5.08%
1 Month
+0.33%
+0.33%
3 Month
+1.69%
+1.69%
6 Month
+5.62%
+5.62%
1 Year
+19.82%
+19.82%

More News

Read More
Why Amgen Stock Is Down Today Despite Solid Q2 Results
Via The Motley Fool
Amgen Faces Near-Term Challenges But Long-Term Growth Prospects Remain Strong: Analyst
Via Benzinga
AMGN Stock Earnings: Amgen Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Amgen's Options: A Look at What the Big Money is Thinking
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
Via Benzinga
Unpacking the Latest Options Trading Trends in Amgen
Via Benzinga
Market Whales and Their Recent Bets on AMGN Options
Via Benzinga
Wall Street Poised For Second Day Of Gains While Bank Of Japan Makes Reassurances; Dollar Strengthens Against Yen, Crude Prices Surge: What's Driving Markets Wednesday?
Via Benzinga
Amgen Undercuts Its Buy Point On Mixed Second-Quarter Report
Via Investor's Business Daily
Amgen Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity'
Via Benzinga
Topics Stocks
Exposures US Equities
Good Stocks, Strategic Options, and a 4.5% Yield: There's a Lot to Like About This Unique ETF
Via The Motley Fool
Topics ETFs
So Much For Expecting The Fed To Stick The Landing
Via Talk Markets
Topics Economy
Exposures Interest Rates
Wall Street Rebounds After Selloff, VIX Falls, Dollar Surges Against Yen: What's Driving Markets Tuesday?
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
3 Biotech Stocks That Could Have Investors Grinning Soon
Via InvestorPlace
Prediction: This Could Be Amgen's Next Massive Growth Opportunity
Via The Motley Fool
US Stocks Set To Open Higher After Monday's Crash, VIX Plummets: Analyst Says Would Have Worried If Market Surged Higher Without Correction
Via Benzinga
Topics Stocks
Exposures US Equities
The Top 3 Biotech Stocks to Buy Now Summer 2024
Via InvestorPlace
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Dividend-Paying ETFs to Secure Your Passive Income Stream
Via InvestorPlace
Topics ETFs
3 Fabulous Growth Stocks to Buy and Hold Forever
Via InvestorPlace
7 Biotech Stocks to Keep on Your Clinical Radar
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.